title: Correspondence article regarding CD68 as a marker of CD8+ lymphoid proliferation suggested by Wobser et al.
authors.affiliation: Leeds Teaching Hospitals, NHS Trust, Leeds, U.K.. k.lecamwasam@doctors.org.uk.
authors.forename: K
authors.initials: K
authors.lastname: Lecamwasam
authors.affiliation: Leeds Teaching Hospitals, NHS Trust, Leeds, U.K.
authors.forename: B
authors.initials: B
authors.lastname: Mathew
authors.affiliation: Leeds Teaching Hospitals, NHS Trust, Leeds, U.K.
authors.forename: D
authors.initials: D
authors.lastname: Gilson
authors.affiliation: Leeds Teaching Hospitals, NHS Trust, Leeds, U.K.
authors.forename: C
authors.initials: C
authors.lastname: Burton
authors.affiliation: Leeds Teaching Hospitals, NHS Trust, Leeds, U.K.
authors.forename: P
authors.initials: P
authors.lastname: Laws
mesh_terms: D000328:Adult; D015703:Antigens, CD / Q000378:metabolism*; D015214:Antigens, Differentiation, Myelomonocytic / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism*; D018414:CD8-Positive T-Lymphocytes / Q000473:pathology*; D049109:Cell Proliferation / Q000502:physiology; D004428:Ear Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis* / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D000097382:CD68 Molecule
chemical_list: D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D016898:Interferon-alpha; C067980:CD68 antigen, human; D000097382:CD68 Molecule